2406 related articles for article (PubMed ID: 19357394)
1. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
Vardiman JW; Thiele J; Arber DA; Brunning RD; Borowitz MJ; Porwit A; Harris NL; Le Beau MM; Hellström-Lindberg E; Tefferi A; Bloomfield CD
Blood; 2009 Jul; 114(5):937-51. PubMed ID: 19357394
[TBL] [Abstract][Full Text] [Related]
2. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Arber DA; Orazi A; Hasserjian R; Thiele J; Borowitz MJ; Le Beau MM; Bloomfield CD; Cazzola M; Vardiman JW
Blood; 2016 May; 127(20):2391-405. PubMed ID: 27069254
[TBL] [Abstract][Full Text] [Related]
3. The implications of revised WHO classification (2008) of chronic myeloid neoplasms.
Găman M; Vlădăreanu AM; Radesi S
Rom J Intern Med; 2011; 49(1):25-30. PubMed ID: 22026249
[TBL] [Abstract][Full Text] [Related]
4. The World Health Organization (WHO) classification of the myeloid neoplasms.
Vardiman JW; Harris NL; Brunning RD
Blood; 2002 Oct; 100(7):2292-302. PubMed ID: 12239137
[TBL] [Abstract][Full Text] [Related]
5. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms.
Vardiman JW
Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474
[TBL] [Abstract][Full Text] [Related]
6. WHO classification of myeloid neoplasms and leukemia.
Wandt H; Haferlach T; Thiede C; Ehninger G
Blood; 2010 Jan; 115(3):748-9; author reply 749-50. PubMed ID: 20093414
[No Abstract] [Full Text] [Related]
7. Proposal for a revised classification of systemic mastocytosis.
Pardanani A; Tefferi A
Blood; 2010 Apr; 115(13):2720-1. PubMed ID: 20360477
[No Abstract] [Full Text] [Related]
8. Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissue: Myeloid Neoplasms.
Loghavi S; Kanagal-Shamanna R; Khoury JD; Medeiros LJ; Naresh KN; Nejati R; Patnaik MM;
Mod Pathol; 2024 Feb; 37(2):100397. PubMed ID: 38043791
[TBL] [Abstract][Full Text] [Related]
9. The cytogenetics of haematological malignancies.
Berger R
Baillieres Clin Haematol; 1992 Oct; 5(4):791-814. PubMed ID: 1308165
[No Abstract] [Full Text] [Related]
10. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.
Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
Ann Oncol; 1999 Dec; 10(12):1419-32. PubMed ID: 10643532
[TBL] [Abstract][Full Text] [Related]
11. Genetic Testing in the Diagnosis and Biology of Myeloid Neoplasms (Excluding Acute Leukemias).
Hasserjian RP; Kelley TW; Weinberg OK; Morgan EA; Fend F
Am J Clin Pathol; 2019 Aug; 152(3):302-321. PubMed ID: 31263893
[TBL] [Abstract][Full Text] [Related]
12. Myeloproliferative neoplasms (BCR-ABL1 negative) and myelodysplastic/myeloproliferative neoplasms: current diagnostic principles and upcoming updates.
Geyer JT; Orazi A
Int J Lab Hematol; 2016 May; 38 Suppl 1():12-9. PubMed ID: 27161873
[TBL] [Abstract][Full Text] [Related]
13. [A revised 4 edition WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 2017: myeloid neoplasms].
Kovrigina AM
Arkh Patol; 2018; 80(6):43-49. PubMed ID: 30585592
[TBL] [Abstract][Full Text] [Related]
14. [Significance of WHO classification for acute leukemia and myelodysplastic syndrome].
Sugiura A; Takeshita A
Rinsho Byori; 2006 Nov; 54(11):1178-86. PubMed ID: 17240841
[TBL] [Abstract][Full Text] [Related]
15. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Arber DA; Orazi A; Hasserjian RP; Borowitz MJ; Calvo KR; Kvasnicka HM; Wang SA; Bagg A; Barbui T; Branford S; Bueso-Ramos CE; Cortes JE; Dal Cin P; DiNardo CD; Dombret H; Duncavage EJ; Ebert BL; Estey EH; Facchetti F; Foucar K; Gangat N; Gianelli U; Godley LA; Gökbuget N; Gotlib J; Hellström-Lindberg E; Hobbs GS; Hoffman R; Jabbour EJ; Kiladjian JJ; Larson RA; Le Beau MM; Loh ML; Löwenberg B; Macintyre E; Malcovati L; Mullighan CG; Niemeyer C; Odenike OM; Ogawa S; Orfao A; Papaemmanuil E; Passamonti F; Porkka K; Pui CH; Radich JP; Reiter A; Rozman M; Rudelius M; Savona MR; Schiffer CA; Schmitt-Graeff A; Shimamura A; Sierra J; Stock WA; Stone RM; Tallman MS; Thiele J; Tien HF; Tzankov A; Vannucchi AM; Vyas P; Wei AH; Weinberg OK; Wierzbowska A; Cazzola M; Döhner H; Tefferi A
Blood; 2022 Sep; 140(11):1200-1228. PubMed ID: 35767897
[TBL] [Abstract][Full Text] [Related]
16. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
Valent P; Sperr WR; Samorapoompichit P; Geissler K; Lechner K; Horny HP; Bennett JM
Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
[TBL] [Abstract][Full Text] [Related]
17. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
18. Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms.
Loghavi S; Wang SA
Surg Pathol Clin; 2019 Sep; 12(3):651-669. PubMed ID: 31352979
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia.
Falini B; Martelli MP
Am J Hematol; 2023 Mar; 98(3):481-492. PubMed ID: 36606297
[TBL] [Abstract][Full Text] [Related]
20. World Health Organization classification of the acute leukemias and myelodysplastic syndrome.
Bennett JM
Int J Hematol; 2000 Aug; 72(2):131-3. PubMed ID: 11039659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
